HCPLive Network
Latest Managed Care Headlines
Wednesday, September 17, 2014
By Pamela N. Roberto, MPP, and Bruce Stuart, PhD
Out-of-plan medication use accounted for a small share of diabetes, hypertension, and hyperlipidemia prescriptions filled by Medicare Part D beneficiaries
Wednesday, September 17, 2014
By John W. Peabody, MD, PhD, DTM&H, FACP; Riti Shimkhada, PhD; Kuo B. Tong, MS; and Matthew B. Zubiller, MBA
The authors describe 5 basic requirements for planning, implementing, and proving clinical utility for diagnostic tests, drawing on recent reimbursement decisions.
Wednesday, September 17, 2014
By Gerry Oster, PhD, and A. Mark Fendrick, MD
The authors comment on the growth of drug plans with tiers for “non-preferred” generics, and argue that most are inconsistent with established principles of formulary design.
Wednesday, September 17, 2014
By Seth Joseph, MBA; Max Sow, MBA; Michael F. Furukawa, PhD; Steven Posnack, MS, MHS; and Mary Ann Chaffee, MS, MA
This is the first empirical evidence to demonstrate increased competition and innovation in the EHR industry as a result of the HITECH program.
Wednesday, September 17, 2014
By Robin R. Whitebird, PhD, MSW; Leif I. Solberg, MD; Nancy A. Jaeckels, BS; Pamela B. Pietruszewski, MA; Senka Hadzic, MPH; Jürgen Unützer, MD, MPH, MA; Kris A. Ohnsorg, MPH, RN; Rebecca C. Rossom, MD, MSCR; Arne Beck, PhD; Kenneth E. Joslyn, MD, MPH; and Lisa V. Rubenstein, MD, MSPH
Factors most important for successful implementation of collaborative care for depression differ for patient activation versus achieving remission; both are critical to program success.
Wednesday, September 17, 2014
By James F. Burke, MD, MS; Sandeep Vijan, MD; Lynette A. Chekan, MBA; Ted M. Makowiec, MBA; Laurita Thomas, MEd; and Lewis B. Morgenstern, MD
Targeting cardiovascular risk reduction interventions to high-risk patients has the potential to reduce cardiovascular racial disparities, improve health, and reduce costs.
Wednesday, September 17, 2014
By Vanja Sikirica, PharmD, MPH; Steven R. Pliszka, MD; Keith A. Betts, PhD; Paul Hodgkins, PhD, MSc; Thomas M. Samuelson, BA; Jipan Xie, MD, PhD; M. Haim Erder, PhD; Ryan S. Dammerman, MD, PhD; Brigitte Robertson, MD; and Eric Q. Wu
A retrospective study of the treatment patterns and economic outcomes associated with off-label atypical antipsychotic use in the treatment of adolescents with attention-deficit/hyperactivity disorder.
Wednesday, September 17, 2014
By Laura Joszt
In a study of 3 hospitals in Massachusetts, more than a quarter of patient orders were considered partially defensive medicine, but they only accounted for 13% of costs.
Wednesday, September 17, 2014
The study, published in the Journal of Clinical Oncology, wants a policy revamp on screening guidelines for the women who fall in this category.
Physician's Money Digest
At no time in history have any people lived as well as we Americans have been living for the past 30 years. Now that we are in a period of economic stagnation, millions are paying a steep price for living the high life and with such abandon.
A coalition of 17 medical associations and trade groups is calling on the US Department of Health and Human Services to amend its reporting 2015 requirements for the Medicare and Medicaid Electronic Health Record Incentive Program.